StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

VivoSim Labs's price to sales ratio was 4.4× on Nov 11, 2026, against 41.7× a year earlier. Over the last 5 years it ranged from 4.4× to 288.9×, with a median of 27.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.4×−29.3
2025Dec 31, 202533.7×−34.9
2024Dec 31, 202468.6×+42.3
2023Dec 29, 202326.3×+18.5
2022Dec 30, 20227.8×−281.2
2021Jan 29, 2021288.9×+11.1
2020Dec 31, 2020277.9×+263.9
2019Dec 31, 201914.0×−14.4
2018Dec 31, 201828.4×−4.8
2017Dec 29, 201733.3×−67.9
2016Dec 30, 2016101.1×−122.3
2015Dec 31, 2015223.4×−263.6
2014Dec 31, 2014487.0×+52.8
2013Nov 29, 2013434.3×+374.0
2012Dec 31, 201260.2×–

More VivoSim Labs figures

See a number that looks wrong?